e-learning
resources
Stockholm 2007
Monday 17.09.2007
New methods to diagnose tuberculosis infection and disease and problems in tuberculosis care
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
DOTS-Plus treatment of MDR-TB patients with psychiatric disorders
S. Y. Grinchenko, A. P. Agarkov, A. G. Khamitova, S. P. Mishustin, T. P. Tonkel, A. K. Strelis, O. V. Anastasov, R. A. Imereli, A. A. Golubkov (Tomsk, Russian Federation; Boston, MA, United States Of America)
Source:
Annual Congress 2007 - New methods to diagnose tuberculosis infection and disease and problems in tuberculosis care
Session:
New methods to diagnose tuberculosis infection and disease and problems in tuberculosis care
Session type:
Electronic Poster Discussion
Number:
1698
Disease area:
Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
S. Y. Grinchenko, A. P. Agarkov, A. G. Khamitova, S. P. Mishustin, T. P. Tonkel, A. K. Strelis, O. V. Anastasov, R. A. Imereli, A. A. Golubkov (Tomsk, Russian Federation; Boston, MA, United States Of America). DOTS-Plus treatment of MDR-TB patients with psychiatric disorders. Eur Respir J 2007; 30: Suppl. 51, 1698
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Expert interview: TB-Machine learning and artificial intelligence as allies in clinical decision
The Relationship Between Functional Status and Fatigue After COVID-19 Infection
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Related content which might interest you:
The depressive syndrome as a response to the TB treatment in MDR TB patients
Source: Annual Congress 2008 - Clinical epidemiology of tuberculosis III
Year: 2008
MDR-TB treatment in prison setting
Source: Annual Congress 2007 - Tuberculosis control in the penitentiary and civilian sector
Year: 2007
The experience of complex treatment of XDR-TB patients
Source: Annual Congress 2009 - Treatment of tuberculosis at times of emerging drug resistance
Year: 2009
Psychiatric disorders in MDR TB patients on the treatment regimens under DOTS-plus programme in Tomsk oblast penitentiary system
Source: Eur Respir J 2001; 18: Suppl. 33, 513s
Year: 2001
Early outcomes in MDR-TB and XDR-TB patients treated with delamanid under compassionate use
Source: Eur Respir J, 50 (1) 1700311; 10.1183/13993003.00311-2017
Year: 2017
Impact of XDR-TB on treatment outcome of MDR-TB patients with standardized regimens
Source: Annual Congress 2008 - The challenge of multidrug-resistant tuberculosis
Year: 2008
Psychiatric issues during the treatment of the patients with multidrug-resistant tuberculosis
Source: Annual Congress 2005 - Resistant and multidrug resistant tuberculosis
Year: 2005
Improving treatment adherence in TB patients using rehabilitation activities for co-morbid addiction conditions within Tomsk penitentiary system
Source: Annual Congress 2007 - Tuberculosis control in the penitentiary and civilian sector
Year: 2007
Experience of Bedaquiline use in treatment of XDR-TB patients
Source: International Congress 2017 – TB: diagnosis, severity and practical management
Year: 2017
Impact of pre-treatment duration by first line drugs on treatment outcomes of patients with MDR-TB
Source: International Congress 2015 – TB treatment: new drugs and drug resistance
Year: 2015
Predisposition to the development of depressive states in patients with M/XDR TB
Source: Virtual Congress 2020 – Tuberculosis and adverse events in different populations
Year: 2020
Prevalence of psychiatric disorders in seriously-ill COPD patients
Source: Annual Congress 2008 - COPD epidemiology
Year: 2008
The clinical features and treatment of cases with MDR TB of adolescents
Source: Annual Congress 2007 - Specific problems in caring for multidrug-resistant tuberculosis and tuberculosis/HIV cases
Year: 2007
Problems of treatment of TB patients suffering from alcohol and drugs addiction
Source: Eur Respir J 2002; 20: Suppl. 38, 369s
Year: 2002
Linezolide in complex treatment of XDR-TB patients
Source: Annual Congress 2011 - Treatment of tuberculosis and adverse drug reactions
Year: 2011
Screening and monitoring of TB infection in rheumatological patients on biologics therapy
Source: Virtual Congress 2021 – Epidemiological aspects of tuberculosis
Year: 2021
MDR TB treatment in prison
Source: Eur Respir J 2002; 20: Suppl. 38, 614s
Year: 2002
Efficacy of treatment of MDR/XDR TB patients with diabetes mellitus
Source: International Congress 2015 – TB treatment: new drugs and drug resistance
Year: 2015
Managing adult and children XDR-TB cases with limited clinical options
Source: International Congress 2018 – CC4 Tuberculosis
Year: 2018
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept